Identification of a RING protein that can interact in vivo with the BRCA1 gene product
- PMID: 8944023
- DOI: 10.1038/ng1296-430
Identification of a RING protein that can interact in vivo with the BRCA1 gene product
Abstract
The hereditary breast and ovarian cancer gene, BRCA1, encodes a large polypeptide that contains the cysteine-rich RING motif, a zinc-binding domain found in a variety of regulatory proteins. Here we describe a novel protein that interacts in vivo with the N-terminal region of BRCA1. This BRCA1-associated RING domain (BARD1) protein contains an N-terminal RING motif, three tandem ankyrin repeats, and a C-terminal sequence with significant homology to the phylogenetically conserved BRCT domains that lie near the C terminus of BRCA1. The BARD1/BRCA1 interaction is disrupted by BRCA1 missense mutations that segregate with breast cancer susceptibility, indicating that BARD1 may be involved in mediating tumour suppression by BRCA1.
Similar articles
-
Conservation of function and primary structure in the BRCA1-associated RING domain (BARD1) protein.Oncogene. 1998 Oct 22;17(16):2143-8. doi: 10.1038/sj.onc.1202123. Oncogene. 1998. PMID: 9798686
-
Binding and recognition in the assembly of an active BRCA1/BARD1 ubiquitin-ligase complex.Proc Natl Acad Sci U S A. 2003 May 13;100(10):5646-51. doi: 10.1073/pnas.0836054100. Epub 2003 May 5. Proc Natl Acad Sci U S A. 2003. PMID: 12732733 Free PMC article.
-
Structure of a BRCA1-BARD1 heterodimeric RING-RING complex.Nat Struct Biol. 2001 Oct;8(10):833-7. doi: 10.1038/nsb1001-833. Nat Struct Biol. 2001. PMID: 11573085
-
Interactions between BRCT repeats and phosphoproteins: tangled up in two.Trends Biochem Sci. 2004 Nov;29(11):579-85. doi: 10.1016/j.tibs.2004.09.010. Trends Biochem Sci. 2004. PMID: 15501676 Review.
-
BRCA1-dependent and independent functions of BARD1.Int J Biochem Cell Biol. 2002 Jun;34(6):582-7. doi: 10.1016/s1357-2725(01)00161-3. Int J Biochem Cell Biol. 2002. PMID: 11943588 Review.
Cited by
-
The role of RAD51 regulators and variants in primary ovarian insufficiency, endometriosis, and polycystic ovary syndrome.NAR Mol Med. 2024 Sep 28;1(4):ugae010. doi: 10.1093/narmme/ugae010. eCollection 2024 Oct. NAR Mol Med. 2024. PMID: 39359934 Free PMC article. Review.
-
FLT1 activation in cancer cells promotes PARP-inhibitor resistance in breast cancer.EMBO Mol Med. 2024 Aug;16(8):1957-1980. doi: 10.1038/s44321-024-00094-2. Epub 2024 Jul 2. EMBO Mol Med. 2024. PMID: 38956205 Free PMC article.
-
Genomic Characterization of Preclinical Prostate Cancer Cell Line Models.Int J Mol Sci. 2024 Jun 1;25(11):6111. doi: 10.3390/ijms25116111. Int J Mol Sci. 2024. PMID: 38892296 Free PMC article.
-
X-ray crystal structure of a designed rigidified imaging scaffold in the ligand-free conformation.Acta Crystallogr F Struct Biol Commun. 2024 May 1;80(Pt 5):107-115. doi: 10.1107/S2053230X2400414X. Epub 2024 May 20. Acta Crystallogr F Struct Biol Commun. 2024. PMID: 38767964 Free PMC article.
-
BRCA1 and 53BP1 regulate reprogramming efficiency by mediating DNA repair pathway choice at replication-associated double-strand breaks.Cell Rep. 2024 Apr 23;43(4):114006. doi: 10.1016/j.celrep.2024.114006. Epub 2024 Mar 30. Cell Rep. 2024. PMID: 38554279 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous
